Dalbavancin Pharmacokinetics and Safety in Children 3 Months to 11 Years of Age

Daniel Gonzalez, John S. Bradley, Jeffrey Blumer, Ram Yogev, Kevin M. Watt, Laura P. James, Debra L. Palazzi, Varsha Bhatt-Mehta, Janice E. Sullivan, Li Zhang, Jennifer Murphy, Xilla T. Ussery, Sailaja Puttagunta, Michael W. Dunne, Michael Cohen-Wolkowiez*

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

42 Scopus citations

Fingerprint

Dive into the research topics of 'Dalbavancin Pharmacokinetics and Safety in Children 3 Months to 11 Years of Age'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science